PYC Therapeutics Limited (ASX:PYC)
1.200
-0.080 (-6.25%)
Oct 17, 2025, 4:10 PM AEST
PYC Therapeutics Market Cap
PYC Therapeutics has a market cap or net worth of 699.91 million as of October 17, 2025. Its market cap has decreased by -11.76% in one year.
Market Cap
699.91M
Enterprise Value
548.32M
Revenue
23.49M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.20
Market Cap Chart
Since March 30, 2005, PYC Therapeutics's market cap has increased from 28.04M to 699.91M, an increase of 2,395.71%. That is a compound annual growth rate of 16.93%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 17, 2025 | 699.91M | 13.64% |
Dec 31, 2024 | 615.92M | 50.00% |
Dec 29, 2023 | 410.62M | 87.08% |
Dec 30, 2022 | 219.48M | -48.89% |
Dec 31, 2021 | 429.43M | -8.19% |
Dec 31, 2020 | 467.71M | 157.34% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
CSL Limited | 106.48B |
Pro Medicus | 30.58B |
Cochlear | 18.75B |
Sonic Healthcare | 10.72B |
Ramsay Health Care | 7.35B |
Telix Pharmaceuticals | 5.73B |
Ansell | 4.86B |
Mesoblast | 3.58B |